Hoya Corp (HOCPY)
121.06
+1.61
(+1.35%)
USD |
OTCM |
May 31, 16:00
Hoya Cash from Financing (Quarterly): -28.53M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -28.53M |
December 31, 2023 | -218.55M |
September 30, 2023 | -294.83M |
June 30, 2023 | -226.56M |
March 31, 2023 | -319.70M |
December 31, 2022 | -173.26M |
September 30, 2022 | -398.26M |
June 30, 2022 | -549.86M |
March 31, 2022 | -557.46M |
December 31, 2021 | -155.39M |
September 30, 2021 | -14.36M |
June 30, 2021 | -223.42M |
March 31, 2021 | -400.31M |
December 31, 2020 | -486.58M |
September 30, 2020 | -19.95M |
June 30, 2020 | -184.33M |
March 31, 2020 | -114.07M |
December 31, 2019 | -250.79M |
September 30, 2019 | -78.08M |
June 30, 2019 | -343.44M |
March 31, 2019 | -3.477M |
December 31, 2018 | -143.31M |
September 30, 2018 | 6.303M |
June 30, 2018 | -155.31M |
March 31, 2018 | -105.70M |
Date | Value |
---|---|
December 31, 2017 | -313.41M |
September 30, 2017 | -486.12M |
June 30, 2017 | -153.76M |
March 31, 2017 | -2.638M |
December 31, 2016 | -72.78M |
September 30, 2016 | -304.69M |
June 30, 2016 | -214.37M |
March 31, 2016 | -515.97M |
December 31, 2015 | -316.75M |
September 30, 2015 | -37.12M |
June 30, 2015 | -476.16M |
March 31, 2015 | -28.49M |
December 31, 2014 | -43.23M |
September 30, 2014 | -285.98M |
June 30, 2014 | -428.09M |
March 31, 2014 | 4.436M |
December 31, 2013 | -124.37M |
September 30, 2013 | -6.564M |
June 30, 2013 | -151.01M |
March 31, 2013 | 13.90M |
December 31, 2012 | -138.65M |
September 30, 2012 | -520.28M |
June 30, 2012 | -189.86M |
March 31, 2012 | 5.075M |
December 31, 2011 | -168.56M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-557.46M
Minimum
Mar 2022
-14.36M
Maximum
Sep 2021
-251.89M
Average
-224.99M
Median
Cash from Financing (Quarterly) Benchmarks
Takeda Pharmaceutical Co Ltd | -450.06M |
Nxera Pharma Co Ltd | -12.29M |
PeptiDream Inc | -5.103M |
Healios KK | 14.90M |
AnGes Inc | -- |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | 481.56M |
Cash from Investing (Quarterly) | -93.32M |
Free Cash Flow | 1.259B |
Free Cash Flow Per Share (Quarterly) | 1.098 |
Free Cash Flow to Equity (Quarterly) | 376.01M |
Free Cash Flow to Firm (Quarterly) | 387.69M |
Free Cash Flow Yield | 2.96% |